Literature DB >> 3748383

Heterogeneity of cognitive impairment in progressive supranuclear palsy, Parkinson's disease, and Alzheimer's disease.

B Pillon, B Dubois, F Lhermitte, Y Agid.   

Abstract

Patterns of cognitive and behavioral impairment were analyzed in patients with progressive supranuclear palsy (PSP), Parkinson's disease (PD), and senile dementia of Alzheimer's type (SDAT), matched for age, sex, manual laterality, educational level, and degree of intellectual deterioration. The scores of the three groups of patients were significantly lower than those of controls and were comparable on tests of verbal and visuospatial functions as well as global memory. Patients with SDAT could be distinguished by the severity of verbal memory disorders; patients with PSP, and to a lesser degree those with PD, by impaired performances on tests sensitive to frontal lobe dysfunction.

Entities:  

Mesh:

Year:  1986        PMID: 3748383     DOI: 10.1212/wnl.36.9.1179

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  38 in total

Review 1.  Executive control functions in degenerative dementias: a comparative review.

Authors:  L M Duke; A W Kaszniak
Journal:  Neuropsychol Rev       Date:  2000-06       Impact factor: 7.444

2.  A comparative technetium 99m hexamethylpropylene amine oxime SPET study in different types of dementia.

Authors:  M O Habert; U Spampinato; J L Mas; M L Piketty; M C Bourdel; J de Recondo; P Rondot; S Askienazy
Journal:  Eur J Nucl Med       Date:  1991

3.  Differential memory and executive functions in demented patients with Parkinson's and Alzheimer's disease.

Authors:  I Litvan; E Mohr; J Williams; C Gomez; T N Chase
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-01       Impact factor: 10.154

Review 4.  Cognitive differences between patients with left-sided and right-sided Parkinson's disease. A review.

Authors:  Nele Verreyt; Gudrun M S Nys; Patrick Santens; Guy Vingerhoets
Journal:  Neuropsychol Rev       Date:  2011-09-29       Impact factor: 7.444

5.  Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up.

Authors:  W M M Schüpbach; N Chastan; M L Welter; J L Houeto; V Mesnage; A M Bonnet; V Czernecki; D Maltête; A Hartmann; L Mallet; B Pidoux; D Dormont; S Navarro; P Cornu; A Mallet; Y Agid
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-12       Impact factor: 10.154

6.  Cognitive functioning after pallidotomy for refractory Parkinson's disease.

Authors:  K Perrine; M Dogali; E Fazzini; D Sterio; E Kolodny; D Eidelberg; O Devinsky; A Beric
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-08       Impact factor: 10.154

Review 7.  Neuropsychological aspects of Parkinson's disease.

Authors:  S A Raskin; J C Borod; J Tweedy
Journal:  Neuropsychol Rev       Date:  1990-09       Impact factor: 7.444

8.  Differing patterns of psychiatric impairment in Alzheimer and demented parkinsonian patients.

Authors:  P Soliveri; M B Zappacosta; L Austoni; P Caffarra; A Scaglioni; D Testa; E Palazzini; T Caraceni; F Girotti
Journal:  Ital J Neurol Sci       Date:  1994-11

9.  Cholinergic cortical circuits in Parkinson's disease and in progressive supranuclear palsy: a transcranial magnetic stimulation study.

Authors:  Raffaele Nardone; Igor Florio; Piergiorgio Lochner; Frediano Tezzon
Journal:  Exp Brain Res       Date:  2005-03-08       Impact factor: 1.972

10.  Cognitive deficits in progressive supranuclear palsy, Parkinson's disease, and multiple system atrophy in tests sensitive to frontal lobe dysfunction.

Authors:  T W Robbins; M James; A M Owen; K W Lange; A J Lees; P N Leigh; C D Marsden; N P Quinn; B A Summers
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-01       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.